loadpatents
name:-0.0046970844268799
name:-0.011687040328979
name:-0.00055694580078125
de Vry; Jean-Marie-Viktor Patent Filings

de Vry; Jean-Marie-Viktor

Patent Applications and Registrations

Patent applications and USPTO patent grants for de Vry; Jean-Marie-Viktor.The latest application filed is for "phenoxyphenyl alkanesulphonates".

Company Profile
0.10.3
  • de Vry; Jean-Marie-Viktor - Rosrath DE
  • De Vry; Jean Marie Viktor - Roesrath DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aryl and heteroaryl sulfonates
Grant 6,919,470 - Heil , et al. July 19, 2
2005-07-19
Phenoxyphenyl alkanesulphonates
App 20040214886 - Heil, Markus ;   et al.
2004-10-28
Phenoxyphenyl alkanesulphonates
Grant 6,756,409 - Heil , et al. June 29, 2
2004-06-29
Substituted .alpha., .beta.-anellated butyrolactones
Grant 6,723,718 - Stolle , et al. April 20, 2
2004-04-20
Aryl and heteroaryl sulfonates
App 20030232802 - Heil, Markus ;   et al.
2003-12-18
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
Grant 6,573,278 - Mittendorf , et al. June 3, 2
2003-06-03
Aryl sulphonamide amino acid esters and analogues
Grant 6,545,050 - Mittendorf , et al. April 8, 2
2003-04-08
Phenoxyphenyl alkanesulphonates
App 20030022934 - Heil, Markus ;   et al.
2003-01-30
Use of known agonists of the central cannabinoid receptor CB1
Grant 6,284,788 - Mittendorf , et al. September 4, 2
2001-09-04
Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
Grant 6,194,428 - Urbahns , et al. February 27, 2
2001-02-27
Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as medicaments
Grant 5,756,515 - Urbahns , et al. May 26, 1
1998-05-26
Method of treating psychosis using azaheterocyclylmethyl
Grant 5,696,136 - Heine , et al. December 9, 1
1997-12-09
Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders
Grant 5,670,525 - Urbahns , et al. September 23, 1
1997-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed